226 related articles for article (PubMed ID: 2324685)
1. Infection of monocytes by human immunodeficiency virus type 1 blocked by inhibitors of CD4-gp120 binding, even in the presence of enhancing antibodies.
Perno CF; Baseler MW; Broder S; Yarchoan R
J Exp Med; 1990 Apr; 171(4):1043-56. PubMed ID: 2324685
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of human immunodeficiency virus (HIV) replication in human monocytes by low titres of anti-HIV antibodies in vitro.
Matsuda S; Gidlund M; Chiodi F; Cafaro A; Nygren A; Morein B; Nilsson K; Fenyö EM; Wigzell H
Scand J Immunol; 1989 Oct; 30(4):425-34. PubMed ID: 2554488
[TBL] [Abstract][Full Text] [Related]
3. Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies.
Sullivan N; Sun Y; Binley J; Lee J; Barbas CF; Parren PW; Burton DR; Sodroski J
J Virol; 1998 Aug; 72(8):6332-8. PubMed ID: 9658072
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the effector function of human monocytes for Mycobacterium avium by human immunodeficiency virus-1 envelope glycoprotein gp120.
Shiratsuchi H; Johnson JL; Toossi Z; Ellner JJ
J Clin Invest; 1994 Feb; 93(2):885-91. PubMed ID: 8113420
[TBL] [Abstract][Full Text] [Related]
5. Fc receptors for IgG (Fc gamma Rs) on human monocytes and macrophages are not infectivity receptors for human immunodeficiency virus type 1 (HIV-1): studies using bispecific antibodies to target HIV-1 to various myeloid cell surface molecules, including the Fc gamma R.
Connor RI; Dinces NB; Howell AL; Romet-Lemonne JL; Pasquali JL; Fanger MW
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9593-7. PubMed ID: 1835086
[TBL] [Abstract][Full Text] [Related]
6. Ability of anti-HIV agents to inhibit HIV replication in monocyte/macrophages or U937 monocytoid cells under conditions of enhancement by GM-CSF or anti-HIV antibody.
Perno CF; Cooney DA; Currens MJ; Rocchi G; Johns DG; Broder S; Yarchoan R
AIDS Res Hum Retroviruses; 1990 Aug; 6(8):1051-5. PubMed ID: 2223241
[TBL] [Abstract][Full Text] [Related]
7. The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis.
Rieber EP; Federle C; Reiter C; Krauss S; Gürtler L; Eberle J; Deinhardt F; Riethmüller G
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10792-6. PubMed ID: 1438278
[TBL] [Abstract][Full Text] [Related]
8. Bispecific antibody targeting of human immunodeficiency virus type 1 (HIV-1) glycoprotein 41 to human macrophages through the Fc IgG receptor I mediates neutralizing effects in HIV-1 infection.
Mabondzo A; Aussage P; Bartholeyns J; Le Naour R; Raoul H; Romet-Lemonne JL; Dormont D
J Infect Dis; 1992 Jul; 166(1):93-9. PubMed ID: 1535093
[TBL] [Abstract][Full Text] [Related]
9. Effect of anti-carbohydrate antibodies on HIV infection in a monocytic cell line (U937).
Hansen JE; Nielsen C; Clausen H; Mathiesen LR; Nielsen JO
Antiviral Res; 1991 Oct; 16(3):233-42. PubMed ID: 1725246
[TBL] [Abstract][Full Text] [Related]
10. Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptors.
Robinson WE; Montefiori DC; Mitchell WM
Virology; 1990 Apr; 175(2):600-4. PubMed ID: 2327077
[TBL] [Abstract][Full Text] [Related]
11. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 1 envelope protein does not stimulate either prostaglandin formation or the expression of prostaglandin H synthase in THP-1 human monocytes/macrophages.
Hui R; Curtis JF; Sumner MT; Shears SB; Glasgow WC; Eling TE
J Virol; 1995 Dec; 69(12):8020-6. PubMed ID: 7494315
[TBL] [Abstract][Full Text] [Related]
13. Lymphocytotropic strains of HIV type 1 when complexed with enhancing antibodies can infect macrophages via Fc gamma RIII, independently of CD4.
Trischmann H; Davis D; Lachmann PJ
AIDS Res Hum Retroviruses; 1995 Mar; 11(3):343-52. PubMed ID: 7540399
[TBL] [Abstract][Full Text] [Related]
14. Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion.
Boyer V; Desgranges C; Trabaud MA; Fischer E; Kazatchkine MD
J Exp Med; 1991 May; 173(5):1151-8. PubMed ID: 1827139
[TBL] [Abstract][Full Text] [Related]
15. Neuronal injury due to HIV-1 envelope protein is blocked by anti-gp120 antibodies but not by anti-CD4 antibodies.
Kaiser PK; Offermann JT; Lipton SA
Neurology; 1990 Nov; 40(11):1757-61. PubMed ID: 2234433
[TBL] [Abstract][Full Text] [Related]
16. Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.
Martín J; LaBranche CC; González-Scarano F
J Virol; 2001 Apr; 75(8):3568-80. PubMed ID: 11264346
[TBL] [Abstract][Full Text] [Related]
17. Interaction with CD4 and antibodies to CD4-induced epitopes of the envelope gp120 from a microglial cell-adapted human immunodeficiency virus type 1 isolate.
Martín-García J; Cocklin S; Chaiken IM; González-Scarano F
J Virol; 2005 Jun; 79(11):6703-13. PubMed ID: 15890908
[TBL] [Abstract][Full Text] [Related]
18. V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies.
Ly A; Stamatatos L
J Virol; 2000 Aug; 74(15):6769-76. PubMed ID: 10888615
[TBL] [Abstract][Full Text] [Related]
19. Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes.
Moulard M; Phogat SK; Shu Y; Labrijn AF; Xiao X; Binley JM; Zhang MY; Sidorov IA; Broder CC; Robinson J; Parren PW; Burton DR; Dimitrov DS
Proc Natl Acad Sci U S A; 2002 May; 99(10):6913-8. PubMed ID: 11997472
[TBL] [Abstract][Full Text] [Related]
20. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
